JP Morgan Chase’s VIVEVE MED INC VIVE Stock Holding History

JP Morgan Chase’s Portfolio VIVE Stock Details VIVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Hold	0	–	–	–	5859
2019 Q4	–	Hold	0	–	–	–	5974
2019 Q3	–	Hold	0	–	–	–	6045
2019 Q2	–	Hold	0	–	–	–	6100
2018 Q2	–	Sell	-4	Closed	-$15K	–	5754
2018 Q1	$15K	Sell	4 -1	-20%	-$4.35K	﹤0.01%	5125
2017 Q4	$26K	Buy	5 +4	+400%	+$20.8K	﹤0.01%	5102
2017 Q3	$5K	Sell	1 -20	-95%	-$123K	﹤0.01%	4801
2017 Q2	$151K	Buy	+21	New	+$157K	﹤0.01%	4061

Other funds holding VIVE

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JCM

Jacobi Capital Management Pittston, Pennsylvania $2.04B AUM 26.26% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

JP Morgan Chase's VIVE Position: Q1 2020 in Review

JP Morgan Chase held its VIVEVE MED INC (VIVE) position steady in Q1 2020 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5859.

JP Morgan Chase first reported a position in VIVE in Q2 2017 and has held it in 4 quarters since. The position peaked at $151K in Q2 2017. 11 funds tracked by Wall St. Rank hold VIVE as of Q1 2020.

JP Morgan Chase held 0 shares of VIVEVE MED INC worth $0 as of Q1 2020.
JP Morgan Chase left its VIVEVE MED INC share count unchanged in Q1 2020.
VIVEVE MED INC made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2020, its #5859 holding.
JP Morgan Chase first reported a position in VIVEVE MED INC in Q2 2017 and has held it in 4 quarters since.
JP Morgan Chase's VIVEVE MED INC position peaked at $151K in Q2 2017.
11 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q1 2020.

Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.